Healthy CD4+ T Lymphocytes are Not Affected by Targeted Therapies Against the PI3K/Akt/mTOR Pathway in T-cell Acute Lymphoblastic Leukemia

Thumbnail
View/ Open

Show full item record

Author
McCubrey, James A.
URI
http://hdl.handle.net/10342/9592
Subject
 T lymphocytes; PI3K/Akt/mTOR signaling; T-acute lymphoblastic leukemia 
Date
2016-08-23
Citation:
APA:
McCubrey, James A.. (August 2016). Healthy CD4+ T Lymphocytes are Not Affected by Targeted Therapies Against the PI3K/Akt/mTOR Pathway in T-cell Acute Lymphoblastic Leukemia. Oncotarget, (7:34), p.. Retrieved from http://hdl.handle.net/10342/9592

Display/Hide MLA, Chicago and APA citation formats.

MLA:
McCubrey, James A.. "Healthy CD4+ T Lymphocytes are Not Affected by Targeted Therapies Against the PI3K/Akt/mTOR Pathway in T-cell Acute Lymphoblastic Leukemia". Oncotarget. 7:34. (.), August 2016. May 23, 2022. http://hdl.handle.net/10342/9592.
Chicago:
McCubrey, James A., "Healthy CD4+ T Lymphocytes are Not Affected by Targeted Therapies Against the PI3K/Akt/mTOR Pathway in T-cell Acute Lymphoblastic Leukemia," Oncotarget 7, no. 34 (August 2016), http://hdl.handle.net/10342/9592 (accessed May 23, 2022).
AMA:
McCubrey, James A.. Healthy CD4+ T Lymphocytes are Not Affected by Targeted Therapies Against the PI3K/Akt/mTOR Pathway in T-cell Acute Lymphoblastic Leukemia. Oncotarget. August 2016; 7(34) . http://hdl.handle.net/10342/9592. Accessed May 23, 2022.
Collections